INTERNATIONAL PATENT: CIRCADIAN THERAPEUTICS LIMITED FILES APPLICATION FOR "DOSAGE REGIMEN FOR 2-BUTYL-9-METHYL-8-(2H-1,2,3-TRIAZOL-2-YL)-9H-PURIN-6-YLAMINE FOR THE ENTRAINMENT OF CIRCADIAN RHYTHM"

GENEVA, July 2 -- CIRCADIAN THERAPEUTICS LIMITED (Oxford Science Enterprises46 Woodstock RoadOxford OX2 6HT) filed a patent application (PCT/GB2024/053136) for "DOSAGE REGIMEN FOR 2-BUTYL-9-METHYL-8-(2H-1,2,3-TRIAZOL-2-YL)-9H-PURIN-6-YLAMINE FOR THE ENTRAINMENT OF CIRCADIAN RHYTHM" on Dec 17, 2024. With publication no. WO/2025/133589, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SNAPE, Michael Frederick (c/o Circadian Therapeutics LimitedOxford Science Enterprises46 Woodstock RoadOxford OX2 6HT), JAGANNATH, Aarti (c/o ...